Taken together, these findings suggest that, although the COL1A1-PDGFB fusion gene may have been involved in the original pathogenesis of DFSP, it was not involved the subsequent acquisition of imatinib resistance. The gene discussed is COL1A1; the disease is dermatofibrosarcoma protuberans.